OraSure Technologies | OSUR - Operating Expenses


OraSure Technologies reported $40.35M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Illumina USD 899M 47M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 646.2M 1.21B Jun/2026
Repligen USD 183M 8.72M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
STAAR Surgical USD 83.43M 7.32M Jun/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Trinity Biotech USD 12.38M 2.44M Dec/2025
Waters USD 527M 592M Jun/2026